GTBP vs MKTX · $17.4M cap vs P/E 13, rev $451.8M
GT Biopharma Inc (GTBP) versus MarketAxess Holdings Inc (MKTX) — a side-by-side from cached financials, not a winner call.
GT Biopharma Inc (GTBP) is a biotechnology company listed on NASDAQ.
MarketAxess Holdings Inc (MKTX) is a capital markets company listed on US.
GTBP does not have a complete income-statement cache yet.
Latest reported MKTX revenue for 2026-06-30 was $451.8M. Net income was $146.0M. Revenue was up 93.6% from 2026-03-31 to 2026-06-30. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
GTBP currently screens at market cap $17.4M. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
Not investment advice. Open the GTBP and MKTX stock pages for the full models.
Not investment advice.